Literature DB >> 23666798

Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.

H R Harach1, Macarena Galíndez, Mónica Campero, G A Ceballos.   

Abstract

This study was conducted to investigate the natural history of undifferentiated thyroid carcinoma (UTC) in the iodine-deficient province of Salta, Argentina, in relation to salt iodization and health care standards. Five hundred ninety-three thyroid cancers diagnosed from 1958 to2012 were reviewed based mainly on the WHO classification and grouped into three periods, one before and two after iodine prophylaxis. The incidence of UTC was analyzed in relation to changing concentrations of potassium iodide (KI) in salt during the prophylaxis period (from 40 to 33.3 mg KI/kg salt), establishment of primary health care centers throughout the region, and use of fine needle aspiration (FNA) cytology. Twenty-nine UTCs were found in the whole series. The frequency of UTC decreased from 15.2 % (9/59 cases) in the first period to 2.6 % (10/381 cases) well after salt iodination (x (2) Fisher's test, p < 0.0002), and the incidence from 1.4/10(6)/year to 0.1/10(6)/year (Student's t test, p < 0.06), respectively. The decline of UTC after iodine prophylaxis occurred even after decreasing concentrations of KI in salt and timely coincided with the establishment of primary health care centers throughout the region and routine use of FNA. The lower rate of UTC after iodine prophylaxis in the province of Salta is mostly related to earlier detection of more differentiated thyroid tumors rather than higher salt iodization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666798     DOI: 10.1007/s12022-013-9248-9

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  51 in total

1.  Carcinoma of the thyroid gland: a statistical study of 390 patients.

Authors:  R N HIRABAYASHI
Journal:  J Clin Endocrinol Metab       Date:  1961-12       Impact factor: 5.958

2.  [Endemic goiter in school children of Salta Province, Argentina].

Authors:  C Morón; M C Pérez Somigliana; J V Nordera; S D'Andrea; R Katz; E Virgili; B Córdoba; G Giménez
Journal:  Arch Latinoam Nutr       Date:  1985-09

3.  Primary malignant tumours of the thyroid: the relationship between histological classification and clinical behaviour.

Authors:  J M Beaugié; C L Brown; I Doniach; J E Richardson
Journal:  Br J Surg       Date:  1976-03       Impact factor: 6.939

4.  Thyroid cancer in an iodide rich area: a histopathological study.

Authors:  E D Williams; I Doniach; O Bjarnason; W Michie
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

5.  Is residence in areas of endemic goiter a risk factor for thyroid cancer?

Authors:  M R Galanti; P Sparén; A Karlsson; L Grimelius; A Ekbom
Journal:  Int J Cancer       Date:  1995-05-29       Impact factor: 7.396

6.  High relative frequency of thyroid papillary carcinoma in northern Portugal.

Authors:  M C Sambade; V S Gonçalves; M Dias; M A Sobrinho-Simões
Journal:  Cancer       Date:  1983-05-01       Impact factor: 6.860

Review 7.  Primary malignant fibrous histiocytoma of the thyroid: review of the literature with two new cases.

Authors:  Kuo-Feng Hsu; Yaoh-Shiang Lin; Chung-Bao Hsieh; Jyh-Cherng Yu; Quan-Yang Duh; Lai-Fa Sheu; Yee-Min Jen; Ming-Lang Shih
Journal:  Thyroid       Date:  2008-01       Impact factor: 6.568

8.  Frequency and morphology of malignant tumours of the thyroid before and after the introduction of iodine-prophylaxis.

Authors:  F Hofstädter
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Authors:  Paula Soares; Jorge Lima; Ana Preto; Patricia Castro; João Vinagre; Ricardo Celestino; Joana P Couto; Hugo Prazeres; Catarina Eloy; Valdemar Máximo; M Sobrinho-Simões
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

10.  Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.

Authors:  Valeria G Antico Arciuch; Marika A Russo; Mariavittoria Dima; Kristy S Kang; Florence Dasrath; Xiao-Hui Liao; Samuel Refetoff; Cristina Montagna; Antonio Di Cristofano
Journal:  Oncotarget       Date:  2011-12
View more
  4 in total

1.  Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.

Authors:  Michael B Zimmermann; Valeria Galetti
Journal:  Thyroid Res       Date:  2015-06-18

2.  Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profile.

Authors:  Yun Huang; Yiming Tao; Xinying Li; Shi Chang; Bo Jiang; Feng Li; Zhi-Ming Wang
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

3.  2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Authors:  Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

4.  Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma.

Authors:  Nikola Besic; Barbara Gazic
Journal:  Radiol Oncol       Date:  2020-05-02       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.